Merz North America

Merz North America is a major subsidiary of the global Merz Group, specializing in the fields of medical aesthetics and neurosciences. The company's portfolio is anchored by flagship products such as Xeomin (incobotulinumtoxinA), a neuromodulator used for both therapeutic and aesthetic indications, and the Radiesse dermal filler. Merz North America operates through two primary business units: Merz Aesthetics, which focuses on self-care and aesthetic medicine, and Merz Therapeutics, which addresses movement disorders and other neurological conditions. Headquartered in Raleigh, North Carolina, the company provides a comprehensive range of treatment options including injectables, energy-based devices like Ultherapy, and specialty pharmaceuticals for rare diseases like Wilson's disease. Merz is recognized for its commitment to innovation and its significant presence in the dermatology and neurology markets across the United States and Canada.